Health Care Delivery

Researchers laid out 6 position statements for the technology in this patient population.

Eli Lilly will gain Dice Therapeutics’ experimental psoriasis drug; about 1.5 million people dropped from Medicaid since April and May; families are uprooting their lives due to transgender care restrictions

Mandy Cohen, MD, MPH, will take over the CDC; abortion activists acknowledge 1 year without Roe v Wade; Bristol Myers Squibb (BMS) challenges Medicare’s drug price negotiation program.

An analysis of Medicaid data from adults in Alabama suggests just more than 50% of patients fail to get ambulatory follow-up care within the recommended 14-day window following a first-time heart failure hospitalization.

These patients experienced overall improvements in objective health outcomes during the crisis compared with before the health emergency.

Ethical analysis of population health management calls for a communitarian vs individual approach, starting with reconceiving “covered lives” as “patient communities.”

Patients who participated in a COVID-19 patient home monitoring program were satisfied with their care and stated that their participation made them less likely to seek care in the emergency department.

Past research shows no meaningfully increased risk of venous thromboembolism (VTE) in patients with more common chronic inflammatory skin diseases.

A study presented at the American Society of Clinical Oncology Annual Meeting found practice- and provider-level racial and ethnic inequities in rates of next-generation sequencing (NGS) testing for patients with advanced non–small cell lung cancer (NSCLC) treated in the community setting.

Project CARA, a perinatal substance exposure clinic, has implemented a contingency management program that targets appointment attendance for patients with any use disorder, regardless of substance or urine drug screen results.

The incidence rate of melanoma in situ (MIS) has sharply risen since 1975.

Biden administration finalizes a deal on covering preventive care despite legal battle; CMS prepares safety net hospital reimbursement plans; over 1 million Americans have been dropped from Medicaid coverage

This international study looked at educational outcomes among adolescents with eczema as influenced by their quality of life living with the chronic inflammatory skin condition.

The Biden administration will impose drug price inflation penalties on drugmakers; a study reveals massive amounts of COVID-19 relief funds were stolen; experimental vaccine nearly doubles survival in patients in a trial.

Moving to co-administration could also help more adults catch up with vaccination recommendations, the authors said.

Findings are based on a retrospective, multicenter study carried out in Spain.

An abstract at the American Society of Clinical Oncology Annual Meeting showed disparities in lung cancer screening rates in an urban, multiethnic community, and patient navigation increased rates overall.

Investigators evaluated long-term outcomes among individuals who have eosinophilic esophagitis (EoE) and initiated first-line treatment with a food elimination diet after experiencing remission following stoppage of proton pump inhibitor monotherapy.

The plan aims to reverse a significant surge in sexually transmitted infections, including gonorrhea, syphilis, and chlamydia.

This study describes financial issues that influenced telemedicine provision and use for patients with chronic conditions and their providers during COVID-19.

A federal appeals court heard argument about whether to freeze preventative health screenings and care in the Affordable Care Act (ACA); Canadian wildfires trigger health threats as smoke descends south; a large study displayed the safety of COVID-19 mRNA vaccines in young children.

Associations between intervention dosage and hospital use outcomes were observed among patients enrolled in a care management program serving individuals with complex needs.

The Enhancing Oncology Model, announced in July 2022 during the final days of its predecessor, the Oncology Care Model (OCM), has a similar framework as the early alternative payment model for oncology in Medicare, but there are key differences in reimbursement and especially in practices’ requirements to take on risk.

The successful collaboration between a primary care–based network of practices and academic researchers demonstrates feasibility and the need for more funding for primary care research.

Merck sues to stop Medicare drug price negotiations; doctors delay lifesaving therapies due to cancer drug shortages; a federal appeals court will hear Affordable Care Act coverage prevention case.